A) Only synaptic excitation B) The balance of synaptic excitation and inhibition C) Only synaptic inhibition D) The release of calcium ions
A) By increasing excitation only B) By enhancing inhibition or reducing excitation C) By completely blocking all neuronal signals D) By destroying motor neurons
A) By increasing dopamine production B) By mimicking or enhancing endogenous inhibitory substances like GABA C) By depleting GABA levels in the brain D) By blocking acetylcholine receptors
A) Exclusively in peripheral nerves B) Cortex, brain stem, or spinal cord C) Only at the neuromuscular junction D) Only in cardiac muscle tissue
A) Not every agent in this class has CNS activity, such as dantrolene B) Because they only act on the spinal cord C) Because they do not affect the nervous system at all D) Because they all act exclusively on peripheral muscles
A) As a centrally acting muscle relaxant B) As a purely peripheral agent C) As a non-steroidal anti-inflammatory drug D) As an antidepressant
A) As a narcotic B) As a directly acting agent C) As an anticonvulsant D) As a centrally acting agent
A) Antipyretic B) Anesthetic C) Analgesic D) Spasmolytic
A) Paracetamol B) Aspirin C) Carisoprodol D) Ibuprofen
A) Diazepam B) Baclofen C) Cyclobenzaprine D) Dantrolene
A) Hypertension B) Type 2 diabetes C) Asthma D) Fibromyalgia
A) No B) Only for elderly patients C) Only in severe cases D) Yes
A) Antibiotics or antivirals B) Opioids or steroids C) Antidepressants or anticonvulsants D) Paracetamol or NSAIDs
A) Barbiturates B) Antidepressants C) Opioids D) NSAIDs
A) Benefit to treatment with NSAIDs B) Complete cure for fibromyalgia C) Reduction in blood pressure D) Immunity to chronic pain
A) No high-quality evidence B) Definitive clinical trial evidence C) Extensive double-blind evidence D) Robust high-quality evidence
A) Yes, carisoprodol is superior to all others B) No drug has been shown to be better than another C) Yes, cyclobenzaprine is the most effective D) Yes, dantrolene is the least effective
A) Dizziness and drowsiness B) Hypertension and tachycardia C) Insomnia and anxiety D) Weight gain and hair loss
A) High risk of causing kidney failure B) Extreme financial cost of manufacturing C) Interference with digestive enzymes D) Possible abuse and interaction with other drugs
A) Brand name popularity and color B) Speed of physical elimination C) Adverse-effect profile, tolerability, and cost D) Recommendation by the World Health Organization
A) Gastrointestinal conditions B) Neurological conditions such as spasticity C) Cardiovascular conditions D) Orthopedic conditions
A) ALS and muscular dystrophy B) Epilepsy and Huntington's disease C) Parkinson's disease and Alzheimer's disease D) Cerebral palsy and multiple sclerosis
A) Renal effects B) CNS effects C) Gastrointestinal effects D) Cardiovascular effects
A) The peripheral nervous system B) The neuromuscular junction C) Skeletal muscle tissue D) The CNS
A) Pain induces spasm and spasm causes pain B) Nerve compression directly triggers pain C) Lactic acid accumulation causes spasms D) Muscle fibers tear during stress
A) Medical consensus fully accepts this theory B) FDA studies have verified this theory C) Strong evidence proves this theory D) Considerable evidence contradicts this theory
A) Cardiologists B) Neurologists C) Rheumatologists D) Orthopedic surgeons
A) To increase stage 4 sleep B) To block pain receptors C) To lower blood pressure D) To prevent morning stiffness
A) Patients build muscle mass overnight B) Patients feel more refreshed in the morning C) Patients heal broken bones faster D) Patients experience immediate weight loss
A) Dantrolene B) Tizanidine C) Metaxalone D) Baclofen
A) Cyclobenzaprine and tizanidine B) Diazepam and carisoprodol C) Baclofen and dantrolene D) Metaxalone and methocarbamol
A) Those with a history of high blood pressure B) Those with seasonal allergies C) Those with a history of drug or alcohol addiction D) Those with lactose intolerance
A) Acetylcholine B) GABA C) Dopamine D) Serotonin
A) Metabolism B) Excitation C) Polarization D) Inhibition
A) 1985 B) 1950 C) 1973 D) 2000
A) Low back pain B) Tension headaches C) Fibromyalgia D) Hypertension
A) Anticoagulants B) Diuretics C) Beta-blockers D) Spasmolytics
A) Permanent muscle relaxation. B) Increased muscle tone and strength. C) Enhanced neurological reflexes. D) Temporary paralysis.
A) Curare. B) Strychnine. C) Belladonna. D) Hemlock.
A) Morphine. B) Cocaine. C) Tubocurarine. D) Atropine.
A) Serotonin. B) Acetylcholine. C) Dopamine. D) Adrenaline.
A) 1977. B) 1943. C) 1959. D) 1962.
A) 1959. B) 1977. C) 1962. D) 1943.
A) August 1943. B) August 1977. C) August 1959. D) August 1962.
A) August 1977. B) August 1985. C) August 1959. D) August 1962.
A) Anticholinergic. B) Benzodiazepine. C) Barbiturate. D) Opioid.
A) Clonidine. B) Atropine. C) Baclofen. D) Diazepam.
A) Tetrazepam. B) Metaxalone. C) Dantrolene. D) Chlorzoxazone.
A) Aspirin. B) Ibuprofen. C) Methocarbamol. D) Penicillin.
A) Paracetamol. B) Mephenoxalone. C) Omeprazole. D) Lisinopril.
A) Meprobamate. B) Cyclobenzaprine. C) Metaxalone. D) Tizanidine.
A) Anticholinergics. B) Methaqualone. C) Clonidine relatives. D) Benzodiazepines.
A) Only in veterinary medicine. B) No. C) Only when combined with antibiotics. D) Yes.
A) Equagesic. B) Dantrolene. C) Baclofen. D) Metaxalone.
A) Codeine syrups. B) Tramadol tablets. C) Morphine patches. D) Fentanyl preparations.
A) Whole opium products. B) Synthetic opium isolates. C) Homeopathic opium dilutions. D) Topical opium creams.
A) Oxycodone. B) Hydrocodone. C) Methadone. D) Ketobemidone.
A) Sodium ions B) Chloride ions C) Potassium ions D) Calcium ions
A) Three B) Two C) One D) Four
A) Na+ B) K+ C) Ca2+ D) Mg2+
A) A flexible sodium channel B) A rigid carbon ring system C) An acetylcholine esterase bridge D) A calcium ion bond
A) Muscle membrane B) Motor end plate C) Skin epithelium D) Central nervous system
A) Reverse polarization B) Endocytosis C) Active transport D) Diffusion
A) Enzyme B) Inhibitor C) Antagonist D) Agonist
A) Dependence B) Kidney failure C) Bone mineralization D) Permanent blindness
A) GABAB receptors B) GABAA receptors C) Ryanodine receptors D) Alpha-2 adrenergic receptors
A) Increased potassium ion conductance B) Increased sodium ion influx C) Decreased chloride ion transport D) Decreased potassium ion conductance
A) It enhances calcium release from the sarcoplasmic reticulum B) It stops all electrical activity in the muscle fiber C) It depresses excitatory feedback from muscles D) It increases excitatory feedback from muscles
A) Mitochondria B) Extracellular fluid C) Cell nucleus D) Sarcoplasmic reticulum
A) Glycine receptor channel B) GABAA receptor channel C) Alpha-2 adrenergic receptor channel D) Ryanodine receptor channel
A) They are completely paralyzed B) They are depressed only slightly C) They are unaffected D) They are stimulated to contract faster
A) Insomnia B) Sedation C) Muscle spasms D) Hyperactivity
A) Increased appetite B) Dry mouth C) Hair loss D) Weight gain
A) High energy B) Improved hearing C) Rapid weight loss D) Blurred vision
A) Hallucinations B) Extreme hunger C) Muscle growth D) Insomnia
A) Slight dry mouth B) Mild drowsiness C) Severe allergic reactions D) Temporary fatigue |